25 XP   0   0   10

Guangdong Marubi Biotechnology Co
Buy, Hold or Sell?

Let's analyse Marubi together

PenkeI guess you are interested in Guangdong Marubi Biotechnology Co. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Guangdong Marubi Biotechnology Co. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Guangdong Marubi Biotechnology Co

I send you an email if I find something interesting about Guangdong Marubi Biotechnology Co.

Quick analysis of Marubi (30 sec.)










What can you expect buying and holding a share of Marubi? (30 sec.)

How much money do you get?

How much money do you get?
¥0.11
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
¥8.10
Expected worth in 1 year
¥9.07
How sure are you?
100.0%

+ What do you gain per year?

Total Gains per Share
¥1.73
Return On Investment
6.2%

For what price can you sell your share?

Current Price per Share
¥27.84
Expected price per share
¥22.96 - ¥32.82
How sure are you?
50%

1. Valuation of Marubi (5 min.)




Live pricePrice per Share (EOD)

¥27.84

Intrinsic Value Per Share

¥-19.53 - ¥-7.55

Total Value Per Share

¥-11.43 - ¥0.55

2. Growth of Marubi (5 min.)




Is Marubi growing?

Current yearPrevious yearGrowGrow %
How rich?$449.5m$436.4m$13m2.9%

How much money is Marubi making?

Current yearPrevious yearGrowGrow %
Making money$24m$34.2m-$10.1m-42.3%
Net Profit Margin10.1%13.9%--

How much money comes from the company's main activities?

3. Financial Health of Marubi (5 min.)




4. Comparing to competitors in the Household & Personal Products industry (5 min.)




  Industry Rankings (Household & Personal Products)  


Richest
#53 / 187

Most Revenue
#60 / 187

Most Profit
#49 / 187

What can you expect buying and holding a share of Marubi? (5 min.)

Welcome investor! Marubi's management wants to use your money to grow the business. In return you get a share of Marubi.

What can you expect buying and holding a share of Marubi?

First you should know what it really means to hold a share of Marubi. And how you can make/lose money.

Speculation

The Price per Share of Marubi is ¥27.84. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Marubi.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Marubi, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ¥8.10. Based on the TTM, the Book Value Change Per Share is ¥0.24 per quarter. Based on the YOY, the Book Value Change Per Share is ¥0.38 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ¥0.19 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Marubi.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 ¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share¥% of Price per Share
Usd Eps0.060.2%0.060.2%0.090.3%0.130.4%0.120.4%
Usd Book Value Change Per Share0.030.1%0.030.1%0.050.2%0.160.6%0.160.6%
Usd Dividend Per Share0.030.1%0.030.1%0.050.2%0.050.2%0.050.2%
Usd Total Gains Per Share0.060.2%0.060.2%0.100.4%0.210.7%0.210.7%
Usd Price Per Share4.66-4.66-4.40-4.92-3.51-
Price to Earnings Ratio77.76-77.76-51.65-44.25-31.61-
Price-to-Total Gains Ratio77.91-77.91-43.62-45.28-45.28-
Price to Book Ratio4.16-4.16-4.05-4.84-3.46-
Price-to-Total Gains Ratio77.91-77.91-43.62-45.28-45.28-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.847488
Number of shares259
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.030.05
Usd Book Value Change Per Share0.030.16
Usd Total Gains Per Share0.060.21
Gains per Quarter (259 shares)15.5053.26
Gains per Year (259 shares)62.00213.05
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
127355249164203
2556911498328416
382104176148492629
4110138238197655842
51371733002468191055
61642083622959831268
719224242434411471481
821927748639313111694
924631254844314751907
1027434661049216392120

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Book Value Change Per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%
Total Gains per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%7.00.00.0100.0%7.00.00.0100.0%

Fundamentals of Marubi

About Guangdong Marubi Biotechnology Co

Guangdong Marubi Biotechnology Co., Ltd. engages in the research and development, design, production, sale, and service of various cosmetics in China. The company provides skin care, make up, and eye care products. It offers its products under the Marubi, Lianhuo, Chunji, and the Love Fire brand names. The company was founded in 2002 and is based in Guangzhou, China.

Fundamental data was last updated by Penke on 2024-04-18 15:15:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Guangdong Marubi Biotechnology Co.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Marubi earns for each ¥1 of revenue.

  • Above 10% is considered healthy but always compare Marubi to the Household & Personal Products industry mean.
  • A Net Profit Margin of 10.1% means that ¥0.10 for each ¥1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Guangdong Marubi Biotechnology Co:

  • The MRQ is 10.1%. The company is making a huge profit. +2
  • The TTM is 10.1%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ10.1%TTM10.1%0.0%
TTM10.1%YOY13.9%-3.8%
TTM10.1%5Y21.1%-11.0%
5Y21.1%10Y21.1%0.0%
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ10.1%4.2%+5.9%
TTM10.1%4.5%+5.6%
YOY13.9%4.8%+9.1%
5Y21.1%5.0%+16.1%
10Y21.1%6.2%+14.9%
1.1.2. Return on Assets

Shows how efficient Marubi is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Marubi to the Household & Personal Products industry mean.
  • 4.3% Return on Assets means that Marubi generated ¥0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Guangdong Marubi Biotechnology Co:

  • The MRQ is 4.3%. Using its assets, the company is less efficient in making profit.
  • The TTM is 4.3%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ4.3%TTM4.3%0.0%
TTM4.3%YOY6.6%-2.3%
TTM4.3%5Y11.5%-7.3%
5Y11.5%10Y13.2%-1.7%
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ4.3%1.5%+2.8%
TTM4.3%1.6%+2.7%
YOY6.6%1.8%+4.8%
5Y11.5%2.0%+9.5%
10Y13.2%2.4%+10.8%
1.1.3. Return on Equity

Shows how efficient Marubi is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Marubi to the Household & Personal Products industry mean.
  • 5.5% Return on Equity means Marubi generated ¥0.05 for each ¥1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Guangdong Marubi Biotechnology Co:

  • The MRQ is 5.5%. Using its investors money, the company is less efficient in making profit.
  • The TTM is 5.5%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ5.5%TTM5.5%0.0%
TTM5.5%YOY8.0%-2.6%
TTM5.5%5Y15.7%-10.3%
5Y15.7%10Y19.9%-4.2%
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ5.5%3.1%+2.4%
TTM5.5%3.3%+2.2%
YOY8.0%3.3%+4.7%
5Y15.7%3.9%+11.8%
10Y19.9%4.4%+15.5%

1.2. Operating Efficiency of Guangdong Marubi Biotechnology Co.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Marubi is operating .

  • Measures how much profit Marubi makes for each ¥1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Marubi to the Household & Personal Products industry mean.
  • An Operating Margin of 0.0% means the company generated ¥0.00  for each ¥1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Guangdong Marubi Biotechnology Co:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY14.0%-14.0%
TTM-5Y18.9%-18.9%
5Y18.9%10Y20.1%-1.2%
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.5%-7.5%
TTM-4.9%-4.9%
YOY14.0%7.5%+6.5%
5Y18.9%7.6%+11.3%
10Y20.1%8.4%+11.7%
1.2.2. Operating Ratio

Measures how efficient Marubi is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Household & Personal Products industry mean).
  • An Operation Ratio of 1.22 means that the operating costs are ¥1.22 for each ¥1 in net sales.

Let's take a look of the Operating Ratio trends of Guangdong Marubi Biotechnology Co:

  • The MRQ is 1.216. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.216. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.216TTM1.2160.000
TTM1.216YOY1.220-0.004
TTM1.2165Y1.105+0.111
5Y1.10510Y1.100+0.004
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2161.309-0.093
TTM1.2161.2160.000
YOY1.2201.114+0.106
5Y1.1051.169-0.064
10Y1.1001.091+0.009

1.3. Liquidity of Guangdong Marubi Biotechnology Co.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Marubi is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Household & Personal Products industry mean).
  • A Current Ratio of 3.35 means the company has ¥3.35 in assets for each ¥1 in short-term debts.

Let's take a look of the Current Ratio trends of Guangdong Marubi Biotechnology Co:

  • The MRQ is 3.347. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.347. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.347TTM3.3470.000
TTM3.347YOY3.427-0.080
TTM3.3475Y3.387-0.040
5Y3.38710Y2.977+0.410
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ3.3471.690+1.657
TTM3.3471.744+1.603
YOY3.4271.644+1.783
5Y3.3871.703+1.684
10Y2.9771.710+1.267
1.3.2. Quick Ratio

Measures if Marubi is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Marubi to the Household & Personal Products industry mean.
  • A Quick Ratio of 0.76 means the company can pay off ¥0.76 for each ¥1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Guangdong Marubi Biotechnology Co:

  • The MRQ is 0.759. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.759. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.759TTM0.7590.000
TTM0.759YOY1.380-0.620
TTM0.7595Y0.856-0.096
5Y0.85610Y0.636+0.220
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7590.766-0.007
TTM0.7590.794-0.035
YOY1.3800.772+0.608
5Y0.8560.876-0.020
10Y0.6360.936-0.300

1.4. Solvency of Guangdong Marubi Biotechnology Co.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Marubi assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Marubi to Household & Personal Products industry mean.
  • A Debt to Asset Ratio of 0.20 means that Marubi assets are financed with 20.5% credit (debt) and the remaining percentage (100% - 20.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Guangdong Marubi Biotechnology Co:

  • The MRQ is 0.205. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.205. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.205TTM0.2050.000
TTM0.205YOY0.160+0.045
TTM0.2055Y0.229-0.024
5Y0.22910Y0.286-0.057
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2050.441-0.236
TTM0.2050.444-0.239
YOY0.1600.461-0.301
5Y0.2290.441-0.212
10Y0.2860.446-0.160
1.4.2. Debt to Equity Ratio

Measures if Marubi is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Marubi to the Household & Personal Products industry mean.
  • A Debt to Equity ratio of 26.3% means that company has ¥0.26 debt for each ¥1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Guangdong Marubi Biotechnology Co:

  • The MRQ is 0.263. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.263. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.263TTM0.2630.000
TTM0.263YOY0.196+0.067
TTM0.2635Y0.309-0.046
5Y0.30910Y0.435-0.125
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2630.785-0.522
TTM0.2630.787-0.524
YOY0.1960.782-0.586
5Y0.3090.818-0.509
10Y0.4350.826-0.391

2. Market Valuation of Guangdong Marubi Biotechnology Co

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ¥1 in earnings Marubi generates.

  • Above 15 is considered overpriced but always compare Marubi to the Household & Personal Products industry mean.
  • A PE ratio of 77.76 means the investor is paying ¥77.76 for every ¥1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Guangdong Marubi Biotechnology Co:

  • The EOD is 64.164. Based on the earnings, the company is expensive. -2
  • The MRQ is 77.761. Based on the earnings, the company is expensive. -2
  • The TTM is 77.761. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD64.164MRQ77.761-13.598
MRQ77.761TTM77.7610.000
TTM77.761YOY51.653+26.108
TTM77.7615Y44.250+33.512
5Y44.25010Y31.607+12.643
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
EOD64.16417.348+46.816
MRQ77.76116.811+60.950
TTM77.76117.303+60.458
YOY51.65319.914+31.739
5Y44.25019.835+24.415
10Y31.60722.062+9.545
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Guangdong Marubi Biotechnology Co:

  • The EOD is -178.900. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -216.814. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -216.814. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-178.900MRQ-216.814+37.913
MRQ-216.814TTM-216.8140.000
TTM-216.814YOY-102.762-114.051
TTM-216.8145Y-64.261-152.553
5Y-64.26110Y-45.900-18.360
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
EOD-178.9009.075-187.975
MRQ-216.8149.846-226.660
TTM-216.81410.204-227.018
YOY-102.7626.596-109.358
5Y-64.26111.631-75.892
10Y-45.90012.359-58.259
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Marubi is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Household & Personal Products industry mean).
  • A PB ratio of 4.16 means the investor is paying ¥4.16 for each ¥1 in book value.

Let's take a look of the Price to Book Ratio trends of Guangdong Marubi Biotechnology Co:

  • The EOD is 3.436. Based on the equity, the company is fair priced.
  • The MRQ is 4.164. Based on the equity, the company is fair priced.
  • The TTM is 4.164. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.436MRQ4.164-0.728
MRQ4.164TTM4.1640.000
TTM4.164YOY4.055+0.110
TTM4.1645Y4.842-0.678
5Y4.84210Y3.459+1.384
Compared to industry (Household & Personal Products)
PeriodCompanyIndustry (mean)+/- 
EOD3.4361.507+1.929
MRQ4.1641.767+2.397
TTM4.1641.811+2.353
YOY4.0552.006+2.049
5Y4.8422.089+2.753
10Y3.4592.717+0.742
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Guangdong Marubi Biotechnology Co compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.2420.2420%0.377-36%1.144-79%1.157-79%
Book Value Per Share--8.1028.1020%7.860+3%6.710+21%5.428+49%
Current Ratio--3.3473.3470%3.427-2%3.387-1%2.977+12%
Debt To Asset Ratio--0.2050.2050%0.160+28%0.229-10%0.286-28%
Debt To Equity Ratio--0.2630.2630%0.196+35%0.309-15%0.435-39%
Dividend Per Share--0.1910.1910%0.353-46%0.344-44%0.352-46%
Eps--0.4340.4340%0.617-30%0.906-52%0.841-48%
Free Cash Flow Per Share---0.156-0.1560%-0.310+99%0.195-180%0.338-146%
Free Cash Flow To Equity Per Share---0.156-0.1560%-0.733+371%0.868-118%0.706-122%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---7.555--------
Intrinsic Value_10Y_min---19.531--------
Intrinsic Value_1Y_max---0.010--------
Intrinsic Value_1Y_min---0.859--------
Intrinsic Value_3Y_max---0.600--------
Intrinsic Value_3Y_min---3.546--------
Intrinsic Value_5Y_max---1.876--------
Intrinsic Value_5Y_min---7.273--------
Market Cap11163840000.000-21%13544746877.20013544746877.2000%12805990652.000+6%14271795505.840-5%10194139647.029+33%
Net Profit Margin--0.1010.1010%0.139-27%0.211-52%0.211-52%
Operating Margin----0%0.140-100%0.189-100%0.201-100%
Operating Ratio--1.2161.2160%1.2200%1.105+10%1.100+10%
Pb Ratio3.436-21%4.1644.1640%4.055+3%4.842-14%3.459+20%
Pe Ratio64.164-21%77.76177.7610%51.653+51%44.250+76%31.607+146%
Price Per Share27.840-21%33.74033.7400%31.870+6%35.570-5%25.407+33%
Price To Free Cash Flow Ratio-178.900+17%-216.814-216.8140%-102.762-53%-64.261-70%-45.900-79%
Price To Total Gains Ratio64.289-21%77.91377.9130%43.617+79%45.283+72%45.283+72%
Quick Ratio--0.7590.7590%1.380-45%0.856-11%0.636+19%
Return On Assets--0.0430.0430%0.066-35%0.115-63%0.132-68%
Return On Equity--0.0550.0550%0.080-32%0.157-65%0.199-73%
Total Gains Per Share--0.4330.4330%0.731-41%1.488-71%1.510-71%
Usd Book Value--449507128.028449507128.0280%436499279.428+3%372130361.269+21%300996050.434+49%
Usd Book Value Change Per Share--0.0330.0330%0.052-36%0.158-79%0.160-79%
Usd Book Value Per Share--1.1201.1200%1.086+3%0.927+21%0.750+49%
Usd Dividend Per Share--0.0260.0260%0.049-46%0.047-44%0.049-46%
Usd Eps--0.0600.0600%0.085-30%0.125-52%0.116-48%
Usd Free Cash Flow---8633608.393-8633608.3930%-17222168.564+99%10801769.690-180%18703006.003-146%
Usd Free Cash Flow Per Share---0.022-0.0220%-0.043+99%0.027-180%0.047-146%
Usd Free Cash Flow To Equity Per Share---0.022-0.0220%-0.101+371%0.120-118%0.098-122%
Usd Market Cap1542842688.000-21%1871884018.4291871884018.4290%1769787908.106+6%1972362138.907-5%1408830099.219+33%
Usd Price Per Share3.847-21%4.6634.6630%4.404+6%4.916-5%3.511+33%
Usd Profit--24072142.10424072142.1040%34262725.491-30%50212765.430-52%46608529.019-48%
Usd Revenue--239323214.487239323214.4870%246967347.575-3%238819429.546+0%221135877.449+8%
Usd Total Gains Per Share--0.0600.0600%0.101-41%0.206-71%0.209-71%
 EOD+3 -5MRQTTM+0 -0YOY+14 -215Y+10 -2510Y+13 -22

3.2. Fundamental Score

Let's check the fundamental score of Guangdong Marubi Biotechnology Co based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1564.164
Price to Book Ratio (EOD)Between0-13.436
Net Profit Margin (MRQ)Greater than00.101
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.759
Current Ratio (MRQ)Greater than13.347
Debt to Asset Ratio (MRQ)Less than10.205
Debt to Equity Ratio (MRQ)Less than10.263
Return on Equity (MRQ)Greater than0.150.055
Return on Assets (MRQ)Greater than0.050.043
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Guangdong Marubi Biotechnology Co based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.925
Ma 20Greater thanMa 5028.705
Ma 50Greater thanMa 10029.571
Ma 100Greater thanMa 20028.141
OpenGreater thanClose27.720
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in CNY. All numbers in thousands.

Summary
Total Assets4,091,224
Total Liabilities838,639
Total Stockholder Equity3,188,072
 As reported
Total Liabilities 838,639
Total Stockholder Equity+ 3,188,072
Total Assets = 4,091,224

Assets

Total Assets4,091,224
Total Current Assets2,237,237
Long-term Assets1,853,987
Total Current Assets
Cash And Cash Equivalents 1,073,009
Short-term Investments 437,776
Net Receivables 69,803
Inventory 151,699
Other Current Assets 474,720
Total Current Assets  (as reported)2,237,237
Total Current Assets  (calculated)2,207,007
+/- 30,230
Long-term Assets
Property Plant Equipment 520,592
Intangible Assets 748,630
Long-term Assets Other 466,151
Long-term Assets  (as reported)1,853,987
Long-term Assets  (calculated)1,735,373
+/- 118,613

Liabilities & Shareholders' Equity

Total Current Liabilities668,472
Long-term Liabilities170,167
Total Stockholder Equity3,188,072
Total Current Liabilities
Short Long Term Debt 100,000
Accounts payable 229,836
Other Current Liabilities 4,541
Total Current Liabilities  (as reported)668,472
Total Current Liabilities  (calculated)334,377
+/- 334,095
Long-term Liabilities
Long term Debt 148,000
Capital Lease Obligations Min Short Term Debt11,683
Long-term Liabilities  (as reported)170,167
Long-term Liabilities  (calculated)159,683
+/- 10,485
Total Stockholder Equity
Retained Earnings 1,827,182
Total Stockholder Equity (as reported)3,188,072
Total Stockholder Equity (calculated)1,827,182
+/- 1,360,890
Other
Capital Stock401,445
Common Stock Shares Outstanding 401,445
Net Invested Capital 3,436,072
Net Working Capital 1,568,765
Property Plant and Equipment Gross 629,883



Balance Sheet

Currency in CNY. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
> Total Assets 
1,508,438
1,597,604
2,116,886
3,436,322
3,795,082
3,761,646
4,091,224
4,091,2243,761,6463,795,0823,436,3222,116,8861,597,6041,508,438
   > Total Current Assets 
1,145,129
1,300,805
1,790,664
3,128,412
2,681,701
1,975,798
2,237,237
2,237,2371,975,7982,681,7013,128,4121,790,6641,300,8051,145,129
       Cash And Cash Equivalents 
941,470
1,103,002
1,563,450
2,101,533
1,669,889
806,096
1,073,009
1,073,009806,0961,669,8892,101,5331,563,4501,103,002941,470
       Short-term Investments 
0
0
0
796,143
820,582
738,086
437,776
437,776738,086820,582796,143000
       Net Receivables 
53,536
53,889
4,621
5,550
5,224
57,398
69,803
69,80357,3985,2245,5504,62153,88953,536
       Inventory 
107,281
112,615
129,084
187,026
138,298
138,431
151,699
151,699138,431138,298187,026129,084112,615107,281
       Other Current Assets 
42,841
27,009
93,509
33,535
42,449
222,922
474,720
474,720222,92242,44933,53593,50927,00942,841
   > Long-term Assets 
363,309
335,053
326,222
307,910
1,113,381
1,785,848
1,853,987
1,853,9871,785,8481,113,381307,910326,222335,053363,309
       Property Plant Equipment 
279,973
263,882
260,293
249,272
246,024
384,140
520,592
520,592384,140246,024249,272260,293263,882279,973
       Intangible Assets 
17,439
17,775
27,638
17,740
18,631
764,557
748,630
748,630764,55718,63117,74027,63817,77517,439
       Other Assets 
33,340
20,493
38,290
40,897
798,837
562,028
0
0562,028798,83740,89738,29020,49333,340
> Total Liabilities 
680,348
643,346
735,022
766,402
794,439
603,185
838,639
838,639603,185794,439766,402735,022643,346680,348
   > Total Current Liabilities 
634,712
619,491
709,386
740,037
786,640
576,548
668,472
668,472576,548786,640740,037709,386619,491634,712
       Short Long Term Debt 
20,600
0
0
0
106,702
0
100,000
100,0000106,70200020,600
       Accounts payable 
197,543
215,947
273,365
212,814
203,126
198,397
229,836
229,836198,397203,126212,814273,365215,947197,543
       Other Current Liabilities 
404,205
279,647
270,743
295,957
369,587
349,843
4,541
4,541349,843369,587295,957270,743279,647404,205
   > Long-term Liabilities 
13,080
23,508
25,637
26,365
7,799
26,637
170,167
170,16726,6377,79926,36525,63723,50813,080
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
2,080
14,676
11,683
11,68314,6762,0800000
       Other Liabilities 
13,080
23,508
25,637
26,365
7,799
11,961
0
011,9617,79926,36525,63723,50813,080
> Total Stockholder Equity
828,090
954,258
1,375,229
2,669,920
2,977,746
3,084,097
3,188,072
3,188,0723,084,0972,977,7462,669,9201,375,229954,258828,090
   Common Stock
360,000
360,000
360,000
401,000
401,000
401,820
0
0401,820401,000401,000360,000360,000360,000
   Retained Earnings 
452,431
584,351
999,629
1,514,737
1,822,747
1,930,098
1,827,182
1,827,1821,930,0981,822,7471,514,737999,629584,351452,431
   Accumulated Other Comprehensive Income 0000000
   Capital Surplus 0000000
   Treasury Stock0000000



Balance Sheet

Currency in CNY. All numbers in thousands.




Cash Flow

Currency in CNY. All numbers in thousands.




Income Statement

Currency in CNY. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue2,124,459
Cost of Revenue-629,003
Gross Profit1,495,4561,495,456
 
Operating Income (+$)
Gross Profit1,495,456
Operating Expense-1,901,942
Operating Income222,517-406,486
 
Operating Expense (+$)
Research Development59,849
Selling General Administrative1,143,560
Selling And Marketing Expenses-
Operating Expense1,901,9421,203,408
 
Net Interest Income (+$)
Interest Income11,223
Interest Expense-6,401
Other Finance Cost-10,348
Net Interest Income15,170
 
Pretax Income (+$)
Operating Income222,517
Net Interest Income15,170
Other Non-Operating Income Expenses-
Income Before Tax (EBT)250,136222,517
EBIT - interestExpense = -6,401
228,002
234,402
Interest Expense6,401
Earnings Before Interest and Taxes (EBIT)-256,536
Earnings Before Interest and Taxes (EBITDA)-
 
After tax Income (+$)
Income Before Tax250,136
Tax Provision-23,273
Net Income From Continuing Ops226,863226,863
Net Income228,002
Net Income Applicable To Common Shares-
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--15,170
 

Technical Analysis of Marubi
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Marubi. The general trend of Marubi is BEARISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Marubi's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-14.3%) Bearish trend (14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Guangdong Marubi Biotechnology Co.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 29.61 < 32.54 < 32.82.

The bearish price targets are: 25.01 > 23.86 > 22.96.

Tweet this
Guangdong Marubi Biotechnology Co Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Guangdong Marubi Biotechnology Co. The current mas is .

The long score for the Moving Averages is 6/14.
The longshort score for the Moving Averages is -2/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Guangdong Marubi Biotechnology Co Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Guangdong Marubi Biotechnology Co. The current macd is -0.67047484.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Marubi price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Marubi. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Marubi price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Guangdong Marubi Biotechnology Co Daily Moving Average Convergence/Divergence (MACD) ChartGuangdong Marubi Biotechnology Co Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Guangdong Marubi Biotechnology Co. The current adx is 26.31.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Marubi shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Guangdong Marubi Biotechnology Co Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Guangdong Marubi Biotechnology Co. The current sar is 26.85.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Guangdong Marubi Biotechnology Co Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Guangdong Marubi Biotechnology Co. The current rsi is 41.93. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Guangdong Marubi Biotechnology Co Daily Relative Strength Index (RSI) ChartGuangdong Marubi Biotechnology Co Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Guangdong Marubi Biotechnology Co. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Marubi price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Guangdong Marubi Biotechnology Co Daily Stochastic Oscillator ChartGuangdong Marubi Biotechnology Co Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Guangdong Marubi Biotechnology Co. The current cci is -71.34614912.

Guangdong Marubi Biotechnology Co Daily Commodity Channel Index (CCI) ChartGuangdong Marubi Biotechnology Co Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Guangdong Marubi Biotechnology Co. The current cmo is -15.99455421.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Guangdong Marubi Biotechnology Co Daily Chande Momentum Oscillator (CMO) ChartGuangdong Marubi Biotechnology Co Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Guangdong Marubi Biotechnology Co. The current willr is -65.26315789.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Marubi is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Guangdong Marubi Biotechnology Co Daily Williams %R ChartGuangdong Marubi Biotechnology Co Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Guangdong Marubi Biotechnology Co.

Guangdong Marubi Biotechnology Co Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Guangdong Marubi Biotechnology Co. The current atr is 0.94125232.

Guangdong Marubi Biotechnology Co Daily Average True Range (ATR) ChartGuangdong Marubi Biotechnology Co Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Guangdong Marubi Biotechnology Co. The current obv is 9,072,767.

Guangdong Marubi Biotechnology Co Daily On-Balance Volume (OBV) ChartGuangdong Marubi Biotechnology Co Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Guangdong Marubi Biotechnology Co. The current mfi is 32.99.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Guangdong Marubi Biotechnology Co Daily Money Flow Index (MFI) ChartGuangdong Marubi Biotechnology Co Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Guangdong Marubi Biotechnology Co.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-23STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-28STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-08BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-22STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-25STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-03ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-04RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-24RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-30CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-08BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.

6.3. Candlestick Patterns

Guangdong Marubi Biotechnology Co Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Guangdong Marubi Biotechnology Co based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.925
Ma 20Greater thanMa 5028.705
Ma 50Greater thanMa 10029.571
Ma 100Greater thanMa 20028.141
OpenGreater thanClose27.720
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Marubi with someone you think should read this too:
  • Are you bullish or bearish on Marubi? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Marubi? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Guangdong Marubi Biotechnology Co

I send you an email if I find something interesting about Guangdong Marubi Biotechnology Co.


Comments

How you think about this?

Leave a comment

Stay informed about Guangdong Marubi Biotechnology Co.

Receive notifications about Guangdong Marubi Biotechnology Co in your mailbox!